What Is Microsilica? Composition, Benefits and How It Improves Concrete Strength

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Industry Outlook 2026: Challenges, Opportunities and Growth Areas
  • Keywords: pyrogenic silica
  • Published: 2026-11-20 08:04:23
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
The KIT-series was first reported by Ryoo's group at Korea Advanced Institute of Science and Technology (KAIST), 95 and the standard materials include KIT-1, KIT-5 and KIT-6. KIT-1 has disordered mesopores and amorphous pore walls, but its pore size is uniform and tunable, and it is more thermally stable than MCM-41. 95 In the meantime, KIT-5 and KIT-6 present well-ordered mesostructure with the space-group symmetry of Fm3̄m and Ia3̄d, respectively. 96, 97 Both the materials also have high particular surface areas, uniform pore size distribution and good stability, making them an excellent catalytic support. In addition, KIT-6 can be used to construct drug delivery systems for antimicrobial therapy, anti-tumor therapy and anti- blastocystosis therapy. 98, 99, 100

What Is Hollow Silica? Structure, Properties and Applications

Dental Grade Silica: Uses in Dental Composites, Toothpaste and Oral Care
Silica Gel Desiccant: How It Works, Types, Capacity and How to Choose
Barium Sulfate vs Silica: Fillers for Coatings and Plastics Compared
Moorthy, M. S. et al. Chitosan oligosaccharide coated mesoporous silica nanoparticles for pH-stimuli responsive drug delivery applications. J. Porours Mater. 26, 217-226 (2019). Post CAS Google Scholar
Wood Coating Matting Agent: How to Achieve a Low-Gloss, Clear Finish

What Is the Formula for Silicon Dioxide? SiO₂ Explained

What is silica (SiO₂)?

alkaline silica sol The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.

What is the difference between fumed silica and precipitated silica?

silica carrier for pesticides

What drives silica raw material prices?

silica powder price

Cite this article: Silica Raw Materials News. "Silica for Sealants: Grades, Functions and Formulation Guide ." Published 2026-11-20 08:04:23. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.